CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-04 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Performance Rights | −5,855 | 0 | ||
| 2024-05-03 | Zovighian Bernard J CEO | Shares withheld for taxes | −527 | $85.06 | $45K | 44,288.9 |
| 2024-05-03 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −634 | $85.06 | $54K | 18,440 |
| 2024-05-03 | Szyman Catherine M. CVP, Critical Care | Shares withheld for taxes | −479 | $85.06 | $41K | 43,222.44 |
| 2024-05-03 | SELLERS ROBERT W.A. SVP, Corporate Controller | Shares withheld for taxes | −106 | $85.06 | $9K | 15,163.2 |
| 2024-05-03 | Lippis Daniel J. CVP, JAPAC | Shares withheld for taxes | −281 | $85.06 | $24K | 17,206.74 |
| 2024-05-03 | Wood Larry L Global President TAVR & Surg | Shares withheld for taxes | −395 | $85.06 | $34K | 213,346.74 |
| 2024-05-03 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Shares withheld for taxes | −37 | $85.06 | $3K | 173,811.81 |
| 2024-05-03 | Chopra Daveen CVP, TMTT | Shares withheld for taxes | −291 | $85.06 | $25K | 22,459 |
| 2024-05-03 | BOBO DONALD E JR CVP,Strategy/Corp Development | Shares withheld for taxes | −479 | $85.06 | $41K | 39,288.72 |
| 2024-05-02 | MUSSALLEM MICHAEL A Director | Option exercise 10b5-1 | +29,350 | $36.75 | $1.1M | 33,835.82 |
| 2024-05-02 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −12,207 | $85.02 | $1.0M | 21,628.82 |
| 2024-05-02 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −17,143 | $84.59 | $1.5M | 4,485.82 |
| 2024-05-02 | MUSSALLEM MICHAEL A Director | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 0 | ||
| 2024-05-01 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Option exercise 10b5-1 | +14,400 | $36.75 | $529K | 188,248.81 |
| 2024-05-01 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Sale 10b5-1 | −2,160 | $84.83 | $183K | 186,088.81 |
| 2024-05-01 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Sale 10b5-1 | −12,240 | $84.11 | $1.0M | 173,848.81 |
| 2024-05-01 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −14,400 | 0 | ||
| 2024-04-30 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +7,250 | $36.75 | $266K | 26,324 |
| 2024-04-30 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −700 | $86.40 | $60K | 25,624 |
Page 26 of 27 · 525 trades